MedTrace Logo

CPAP in Diabetes Type 2 Patients With Sleep Apnea

NCT01801150 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 61

Last updated 2015-03-24

No results posted yet for this study

Summary

Aim: To assess if six months of treatment with CPAP associated with conventional drug therapy, contribute to improved glycemic control in patients with type 2 diabetes and sleep apnea-hypopnea syndrome SAHS)

Conditions

Interventions

DEVICE

CPAP nasal treatment

Treatment with titred CPAP nasal during the nighttime

Sponsors & Collaborators

  • Hospital Universitario La Paz

    lead OTHER

Principal Investigators

  • Francisco Garcia-Rio, MD · Hospital Universitario La Paz, IdiPAZ

  • Elizabet Martínez-Cerón, MD · Hospital Universitario La Paz, IdiPAZ

  • Alberto Alonso-Fernández, MD · Hospital Son Espasses

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-31
Primary Completion
2014-12-31
Completion
2015-01-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01801150 on ClinicalTrials.gov